Skip to main content
OpenTrials
Completed

NCT Number: NCT01207843

Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias

Hepatic candidiasis is a frequent complication in patients receiving intensive chemotherapy for acute leukemia. Hepatic lesions may be detected by computerized tomographic (CT) scans, but there is no standardized CT protocol for the diagnosis and follow-up of hepatic candidiasis.

The investigators compared the size of the fungal lesions in the chest and abdomen CT. The current analysis aimed to increase the value of CT for the diagnosis and the follow-up of hepatic candidiasis in daily routine.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Zurich, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chest and Abdomen CT with fungal lesion in patients with leukemia

Exclusion criteria

  • Other liver pathologies

Treatment and study plan

Imaging

Behavioral

CT image validation and lesion measurement, as well as comparison of different CT phases

Primary outcomes

  1. The primary end-point was IFI according to the EORTC/MSG 2008 definitions and bacteraemia

    Time frame: 2 Years

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Verbesserung Der Radiologischen Diagnose Von Hepatolienaler Candidiasis während Der Therapie Der Leukämie

Important dates

Study start
2009
Primary completion
2011
Study completion
2013
First posted
Sep 23, 2010
Registry last updated
Aug 19, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.